NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/15/2026
Back to search
Official data from USPTO
BIOLOGICS CONSULTING
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
08/15/2026
Trademark type
Combined
Nice classes
35, 42, 45
Filing date
09/10/2015
Registration date
03/28/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/15/2026
Last transaction
08/15/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/15/2016
First use in commerce
01/15/2016
Drawing code
3
Owner type
03
Owner location
Alexandria, VA, US
Examiner
BROWN, TRICIA
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "BIOLOGICS" above "CONSULTING" with the design of connecting circles to the left of such words.
Holders and representatives
Holders
Biologics Consulting Group, Inc.
Representatives
Nicole J. Harrell Kaufman & Canoles, P.C.
Technical classification
Nice Classes
Class 35Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; regulatory submission managementassisting others in preparing and filing applications for new medical devicesmedical technologiesmedicationsbiopharmaceuticalsbiotechnology with governmental regulatory bodies around the world; regulatory submission managementproviding simultaneous multiple country submissions of applications for the registration and approval of medical devicesmedical technologiesmedicationsbiopharmaceuticalsbiotechnology; providing information online regarding regulatory submission management; business management consultingstrategic planning and business advisory services provided to medicalmedical technologybiopharmaceuticalbiotechnology companiesgovernment agencieseducational and research institutionslaw firmsinvestment firms in the fields of biologicspharmaceuticals and medical devices; providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for drug and medical device approval; regulatory submission managementassisting others in preparing and filing applications for new drugs and medical devices with governmental regulatory bodies; business consulting services in the field of biologicspharmaceuticalsprescription drugs and medical devices
Class 42
Consulting services for others in the field of designing pre-clinical and clinical studies and trials for others; product research and development for others in the fields of biologicspharmaceuticalsprescription drugs and medical devices; quality management servicesquality evaluation and analysisquality assurance and quality control in the field of biologicspharmaceuticalsprescription drugs and medical devices; scientific consulting and research services relating to the field of pharmaceuticalsmedical deviceslife sciencesbiologymedicine; consulting services in the fields of biotechnology and pharmaceuticalsdesigndevelopmenttechnical verification and technical validation of manufacturing and filling processesdrug formulationstesting protocols and analytical methods; and scientific and technological servicesscientific researchanalysistestingrelated scientific studies in the field of chemistry and molecular biologybiologics and protein detectioncharacterizationanalysis and testing; consulting services in the field of medical device product approval for commercial purposes
Class 45
Regulatory compliance consulting servicesreviewing standards and practices to assist clients with compliance with governmental lawsregulations and rules in the fields of medical devicesmedical technologiesmedicationsbiopharmaceuticalsbiotechnology; providing technical regulatory affair consulting services directed to medicalmedical technologybiopharmaceuticalbiotechnology companies in order to assure compliance with food and drug administration's laws and regulations; provision of information online pertaining to regulatory compliance in the fields of medical devicesmedical technologiesmedicationsbiopharmaceuticalsbiotechnology; and regulatory compliance consulting in the fields of biologicspharmaceuticalsprescription drugs and medical devices
Publications
History of USPTO decisions and trademark events.
41 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/15/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/15/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/15/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
06/17/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/28/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/27/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/27/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/27/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/27/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/27/2025
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
04/21/2025
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
04/21/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/18/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/18/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/18/2023
E815
TEAS SECTION 8 & 15 RECEIVED
03/16/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/28/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
03/28/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/22/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/21/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/03/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/03/2017
IUAF
USE AMENDMENT FILED
01/16/2017
EISU
TEAS STATEMENT OF USE RECEIVED
01/16/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/16/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/21/2016
PUBO
PUBLISHED FOR OPPOSITION
06/21/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/01/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/18/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
05/18/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/18/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
05/18/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/18/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/04/2016
GNRT
NON-FINAL ACTION E-MAILED
01/04/2016
CNRT
NON-FINAL ACTION WRITTEN
01/04/2016
DOCK
ASSIGNED TO EXAMINER
12/22/2015
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/16/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/15/2015
NWAP
NEW APPLICATION ENTERED
09/14/2015
Continuous trademark protection
Get notified about every new filing that threatens BIOLOGICS CONSULTING or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.